| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $928.7M | +21.1% |
| Cost of Revenue | $430.6M | +20.2% |
| R&D Expense | $126.8M | +13.4% |
| SG&A Expense | $81.2M | +11.1% |
| Operating Income | $209.9M | +37.4% |
| Pre-tax Income | $213.7M | +35.1% |
| Income Tax | $37.1M | +27.2% |
| Net Income | $176.6M | +36.9% |
| EPS (Basic) | $2.86 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $270.7M | +20.1% |
| Accounts Receivable | $181.2M | +8.6% |
| Current Assets | $479.2M | +15.4% |
| Total Assets | $673.4M | +18.1% |
| Current Liabilities | $365.9M | +15.9% |
| Stockholders' Equity | $278.3M | +22.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $246.2M | +37.1% |
| Capital Expenditures | $4.7M | -28.2% |
| Investing Cash Flow | -$4.7M | +28.2% |
| Financing Cash Flow | -$196.0M | +4.1% |
| Free Cash Flow | $241.5M | +39.6% |
| +39.5% |
| EPS (Diluted) | $2.82 | +38.9% |